288eTiP A multicenter, open-label, first-in-human study of TYRA-430 in advanced hepatocellular carcinoma and other solid tumors with activating FGF/FGFR pathway aberrations (SURF431). - Goyal, L.; Al-Rajabi, R.; Sahin, I.; Subbiah, V.; Vogel, A.; Yarchoan, M.; Pierpont, S.; Huang, X.; Burn, T.; Lihou, C.; Goluboff, E.; Zalutskaya, A. (Annals of Oncology, 2025)